{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:20:44Z","timestamp":1795040444984,"version":"4.10.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM109025"],"award-info":[{"award-number":["P20GM109025"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>We examined interactive effects of sex, diagnosis, and cerebrospinal fluid (CSF) amyloid beta\/phosphorylated tau ratio (A\u03b2\/P-tau) on verbal memory and hippocampal volumes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We assessed 682 participants (350 women) from BioFINDER (250 cognitively normal [CN]; and 432 symptomatic: 186 subjective cognitive decline [SCD], 246 mild cognitive impairment [MCI]). General linear models evaluated effects of Alzheimer\u2019s disease (AD) proteinopathy (CSF A\u00df\/p-tau ratio), diagnosis, and sex on verbal memory (ADAS-cog 10-word recall), semantic fluency (animal naming fluency), visuospatial skills (cube copy), processing speed\/attention functions (Symbol Digit Modalities Test and Trail Making Part A), and hippocampal volumes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Amyloid-positive (A\u03b2\/P-tau+) CN women (women with preclinical AD) showed memory equivalent to amyloid-negative (A\u03b2\/P-tau\u2212) CN women. In contrast, A\u03b2\/P-tau+ CN men (men with preclinical AD) showed poorer memory than A\u03b2\/P-tau\u2212 CN men. Symptomatic groups showed no sex differences in effect of AD proteinopathy on memory. There was no interactive effect of sex, diagnosis, and A\u03b2\/P-tau on other measures of cognition or on hippocampal volume.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>CN women show relatively preserved verbal memory, but not general cognitive reserve or preserved hippocampal volume in the presence of A\u03b2\/P-tau+. Results have implications for diagnosing AD in women, and for clinical trials.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13195-019-0565-1","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T15:02:42Z","timestamp":1577372562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cognitively normal women with Alzheimer\u2019s disease proteinopathy show relative preservation of memory but not of hippocampal volume"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2849-2679","authenticated-orcid":false,"given":"Jessica Z. K.","family":"Caldwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Palmqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,26]]},"reference":[{"issue":"18","key":"565_CR1","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/WNL.0000000000003288","volume":"87","author":"Erin E. Sundermann","year":"2016","unstructured":"Sundermann EE, Maki PM, Rubin LH, Lipton RB, Landau S, Biegon A. Female advantage in verbal memory evidence of sex-specific cognitive reserve. Neurology. 2016. https:\/\/doi.org\/10.1212\/WNL.0000000000003288.","journal-title":"Neurology"},{"issue":"15","key":"565_CR2","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1212\/WNL.0000000000002570","volume":"86","author":"Erin E. Sundermann","year":"2016","unstructured":"Sundermann EE, Biegon A, Rubin LH, Lipton RB, Mowrey W, Landau S, et al. Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy. Neurology. 2016. https:\/\/doi.org\/10.1212\/WNL.0000000000002570.","journal-title":"Neurology"},{"key":"565_CR3","doi-asserted-by":"publisher","unstructured":"Caldwell JZK, Berg J-L, Cummings JL, Banks SJ. Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume. Alzheimers Res Ther. 2017. https:\/\/doi.org\/10.1186\/s13195-017-0300-8.","DOI":"10.1186\/s13195-017-0300-8"},{"key":"565_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3233\/JAD-160716","volume":"56","author":"EE Sundermann","year":"2017","unstructured":"Sundermann EE, Biegon A, Rubin LH, Lipton RB, Landau S, Maki PM. Does the female advantage in verbal memory contribute to underestimating Alzheimer\u2019s disease pathology in women versus men? J Alzheimers Dis. 2017;56:947\u201357.","journal-title":"J Alzheimers Dis"},{"key":"565_CR5","doi-asserted-by":"publisher","unstructured":"Brunet H, Caldwell JZK, Brandt J, Miller JB. Influence of sex differences in interpreting learning and memory within a clinical sample of older adults. Aging Neuropsychol Cogn. 2019. https:\/\/doi.org\/10.1080\/13825585.2019.1566433.","DOI":"10.1080\/13825585.2019.1566433"},{"issue":"9","key":"565_CR6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jalz.2018.04.010","volume":"14","author":"Rachel F. Buckley","year":"2018","unstructured":"Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, et al. Sex, amyloid, and APOE \u03b54 and risk of cognitive decline in preclinical Alzheimer\u2019s disease: findings from three well-characterized cohorts. Alzheimers Dement. 2018. https:\/\/doi.org\/10.1016\/j.jalz.2018.04.010.","journal-title":"Alzheimer's & Dementia"},{"key":"565_CR7","doi-asserted-by":"publisher","unstructured":"Sohn D, Shpanskaya K, Lucas JE, Petrella JR, Saykin AJ, Tanzi RE, et al. Sex differences in cognitive decline in subjects with high likelihood of mild cognitive impairment due to Alzheimer\u2019s disease. Sci Rep. 2018. https:\/\/doi.org\/10.1038\/s41598-018-25377-w.","DOI":"10.1038\/s41598-018-25377-w"},{"issue":"2","key":"565_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/08952841.2018.1419476","volume":"31","author":"Shanna L. Burke","year":"2018","unstructured":"Burke SL, Hu T, Fava NM, Li T, Rodriguez MJ, Schuldiner KL, et al. Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging. 2018. https:\/\/doi.org\/10.1080\/08952841.2018.1419476.","journal-title":"Journal of Women & Aging"},{"key":"565_CR9","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1046\/j.1471-4159.1996.66051836.x","volume":"66","author":"Y Goodman","year":"1996","unstructured":"Goodman Y, Bruce AJ, Cheng B, Mattson MP. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid-peptide toxicity in hippocampal neurons. J Neurochem. 1996;66:1836\u201344.","journal-title":"J Neurochem"},{"issue":"9","key":"565_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jalz.2018.04.008","volume":"14","author":"Rebecca A. Nebel","year":"2018","unstructured":"Nebel RA, Aggarwal NT, Barnes LL, Gallagher A, Goldstein JM, Kantarci K, et al. Understanding the impact of sex and gender in Alzheimer\u2019s disease: a call to action. Alzheimers Dement. 2018. https:\/\/doi.org\/10.1016\/j.jalz.2018.04.008.","journal-title":"Alzheimer's & Dementia"},{"issue":"4","key":"565_CR11","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1046\/j.1471-4159.1999.721552.x","volume":"72","author":"Christian J. Pike","year":"2001","unstructured":"Pike CJ. Estrogen modulates neuronal Bcl-x(L) expression and-amyloid-induced apoptosis: relevance to Alzheimer\u2019s disease. J Neurochem. 1999. https:\/\/doi.org\/10.1046\/j.1471-4159.1999.721552.x.","journal-title":"Journal of Neurochemistry"},{"issue":"10","key":"565_CR12","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","volume":"74","author":"Scott C. Neu","year":"2017","unstructured":"Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, et al. Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis. JAMA Neurol. 2017. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2188.","journal-title":"JAMA Neurology"},{"key":"565_CR13","doi-asserted-by":"publisher","unstructured":"Mangold CA, Wronowski B, Du M, Masser DR, Hadad N, Bixler GV, et al. Sexually divergent induction of microglial-associated neuroinflammation with hippocampal aging. J Neuroinflammation. 2017. https:\/\/doi.org\/10.1186\/s12974-017-0920-8.","DOI":"10.1186\/s12974-017-0920-8"},{"key":"565_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neurobiolaging.2016.02.011","volume":"42","author":"Liqin Zhao","year":"2016","unstructured":"Zhao L, Mao Z, Woody SK, Brinton RD. Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer\u2019s disease. Neurobiol Aging. 2016. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.02.011.","journal-title":"Neurobiology of Aging"},{"key":"565_CR15","series-title":"Oxford Handbooks Online","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordhb\/9780199988693.013.0021","volume-title":"Memory Consolidation","author":"John Wixted","year":"2013","unstructured":"Wixted JT, Cai DJ. Memory consolidation. Oxford Handb Cogn Neurosci. 2013:1\u201359. https:\/\/doi.org\/10.1093\/oxfordhb\/9780199988693.013.0021."},{"issue":"4","key":"565_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H. Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991. https:\/\/doi.org\/10.1007\/BF00308809.","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"565_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/JAD-180028","volume":"64","author":"Jessica Z.K. Caldwell","year":"2018","unstructured":"Caldwell JZK, Berg JL, Shan G, Cummings JL, Banks SJ. Sex moderates the impact of diagnosis and amyloid PET positivity on hippocampal subfield volume. J Alzheimers Dis. 2018. https:\/\/doi.org\/10.3233\/JAD-180028.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"3","key":"565_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3233\/JAD-170203","volume":"59","author":"Emma Borland","year":"2017","unstructured":"Borland E, N\u00e4gga K, Nilsson PM, Minthon L, Nilsson ED, Palmqvist S. The Montreal cognitive assessment: normative data from a large Swedish population-based cohort. J Alzheimers Dis. 2017. https:\/\/doi.org\/10.3233\/JAD-170203.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"5","key":"565_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0277-9536(02)00454-9","volume":"57","author":"Martijn Huisman","year":"2003","unstructured":"Huisman M, Kunst AE, Mackenbach JP. Socioeconomic inequalities in morbidity among the elderly: a European overview. Soc Sci Med. 2003. https:\/\/doi.org\/10.1016\/S0277-9536(02)00454-9.","journal-title":"Social Science & Medicine"},{"key":"565_CR20","unstructured":"The Swedish BIOFINDER Study. Available from: http:\/\/biofinder.se. Accessed 19 Oct 2018."},{"issue":"3","key":"565_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"Marshal F. Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6.","journal-title":"Journal of Psychiatric Research"},{"key":"565_CR22","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington DC: American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"10","key":"565_CR23","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/jamaneurol.2014.1358","volume":"71","author":"Sebastian Palmqvist","year":"2014","unstructured":"Palmqvist S, Zetterberg H, Blennow K, Vestberg S, Andreasson U, Brooks DJ, et al. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid \u03b2-amyloid 42: a cross-validation study against amyloid positron emission tomography. JAMA Neurol. 2014. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1358.","journal-title":"JAMA Neurology"},{"issue":"11","key":"565_CR24","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"Oskar Hansson","year":"2018","unstructured":"Hansson O, Seibyl J, Stomrud E, Zetterberg H, Trojanowski JQ, Bittner T, et al. CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement. 2018. https:\/\/doi.org\/10.1016\/j.jalz.2018.01.010.","journal-title":"Alzheimer's & Dementia"},{"key":"565_CR25","doi-asserted-by":"publisher","unstructured":"Palmqvist S, Sch\u00f6ll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, et al. Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun. 2017. https:\/\/doi.org\/10.1038\/s41467-017-01150-x.","DOI":"10.1038\/s41467-017-01150-x"},{"key":"565_CR26","doi-asserted-by":"publisher","unstructured":"Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer\u2019s disease. Am J Psychiatry. 1984. https:\/\/doi.org\/10.1176\/ajp.141.11.1356.","DOI":"10.1176\/ajp.141.11.1356"},{"issue":"5","key":"565_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1467-9450.2008.00653.x","volume":"49","author":"I. M. TALLBERG","year":"2008","unstructured":"Tallberg IM, Ivachova E, Jones Tinghag K, Ostberg P. Swedish norms for word fluency tests: FAS, animals and verbs. Scand J Psychol. 2008. https:\/\/doi.org\/10.1111\/j.1467-9450.2008.00653.x.","journal-title":"Scandinavian Journal of Psychology"},{"issue":"5","key":"565_CR28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/1533317508320084","volume":"23","author":"Sebastian Palmqvist","year":"2008","unstructured":"Palmqvist S, Hansson O, Minthon L, Londos E. The usefulness of cube copying for evaluating treatment of Alzheimer\u2019s disease. Am J Alzheimers Dis Other Dement. 2008. https:\/\/doi.org\/10.1177\/1533317508320084.","journal-title":"American Journal of Alzheimer's Disease & Other Dementiasr"},{"issue":"5","key":"565_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1037\/h0044509","volume":"19","author":"Ralph M. Reitan","year":"1955","unstructured":"Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol. 1955. https:\/\/doi.org\/10.1037\/h0044509.","journal-title":"Journal of Consulting Psychology"},{"key":"565_CR30","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000258542.58725.4c","volume-title":"Clinical predictors of progression to Alzheimer\u2019s disease in amnestic mild cognitive impairment","author":"AS Fleisher","year":"2007","unstructured":"Fleisher AS, Sowell BB, Taylor C, Peterson RC, Thal LJ, et al. Clinical predictors of progression to Alzheimer\u2019s disease in amnestic mild cognitive impairment; 2007. https:\/\/doi.org\/10.1212\/01.wnl.0000258542.58725.4c."},{"issue":"6","key":"565_CR31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"Frank Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, Van Boxtel M, Breteler M, Ceccaldi M, Ch\u00e9telat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease and Subjective Cognitive Decline Initiative (SCD-I) working group. Alzheimers Dement. 2014. https:\/\/doi.org\/10.1016\/j.jalz.2014.01.001.","journal-title":"Alzheimer's & Dementia"},{"issue":"5","key":"565_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jalz.2012.08.004","volume":"9","author":"Argonde C. van Harten","year":"2013","unstructured":"Van Harten AC, Visser PJ, Pijnenburg YAL, Teunissen CE, Blankenstein MA, Scheltens P, et al. Cerebrospinal fluid A\u03b242 is the best predictor of clinical progression in patients with subjective complaints. Alzheimers Dement. 2013. https:\/\/doi.org\/10.1016\/j.jalz.2012.08.004.","journal-title":"Alzheimer's & Dementia"},{"issue":"3","key":"565_CR33","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3233\/JAD-170425","volume":"61","author":"Erin E. Sundermann","year":"2018","unstructured":"Sundermann E, Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Rubin LH, et al. Sex influences the accuracy of subjective memory complaint reporting in older adults. J Alzheimers Dis. 2018. https:\/\/doi.org\/10.3233\/JAD-170425.","journal-title":"Journal of Alzheimer's Disease"},{"key":"565_CR34","doi-asserted-by":"publisher","unstructured":"Buckley RF, Villemagne VL, Masters CL, Ellis KA, Rowe CC, Johnson KA, et al. A conceptualization of the utility of subjective cognitive decline in clinical trials of preclinical Alzheimer\u2019s disease. J Mol Neurosci. 2016. https:\/\/doi.org\/10.1017\/S0954579414000868.Child-evoked.","DOI":"10.1017\/S0954579414000868.Child-evoked"},{"issue":"11","key":"565_CR35","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1002\/hbm.22576","volume":"35","author":"Stine K. Krogsrud","year":"2014","unstructured":"Krogsrud SK, Tamnes CK, Fjell AM, Amlien I, Grydeland H, Sulutvedt U, et al. Development of hippocampal subfield volumes from 4 to 22 years. Hum Brain Mapp. 2014. https:\/\/doi.org\/10.1002\/hbm.22576.","journal-title":"Human Brain Mapping"},{"issue":"3","key":"565_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3233\/JAD-150780","volume":"50","author":"Babak A. Ardekani","year":"2016","unstructured":"Ardekani BA, Convit A, Bachman AH. Analysis of the MIRIAD data shows sex differences in hippocampal atrophy progression. J Alzheimers Dis. 2016. https:\/\/doi.org\/10.3233\/JAD-150780.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1","key":"565_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neurobiolaging.2014.07.036","volume":"36","author":"Rachel L. Nosheny","year":"2015","unstructured":"Nosheny RL, Insel PS, Truran D, Schuff N, Jack CR, Aisen PS, et al. Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment. Neurobiol Aging. 2015. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.036.","journal-title":"Neurobiology of Aging"},{"key":"565_CR38","doi-asserted-by":"publisher","unstructured":"Marrocco J, McEwen BS. Sex in the brain: Hormones and sex differences. Dialogues Clin Neurosci. 2016. https:\/\/doi.org\/10.12032\/TMR201705034.","DOI":"10.12032\/TMR201705034"},{"key":"565_CR39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neurobiolaging.2019.02.019","volume":"78","author":"Rachel F. Buckley","year":"2019","unstructured":"Buckley RF, Mormino EC, Chhatwal J, Schultz AP, Rabin JS, Rentz DM, et al.; for the Alzheimer\u2019s Disease Neuroimaging Initiative. Associations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid. Neurobiol Aging. 2019; doi: https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.02.019.","journal-title":"Neurobiology of Aging"},{"key":"565_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jsbmb.2016.03.012","volume":"160","author":"Brandalyn C. Riedel","year":"2016","unstructured":"Riedel BC, Thompson PM, Brinton RD. Age, APOE and sex: triad of risk of Alzheimer\u2019s disease. J Steroid Biochem Mol Biol. 2016. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.03.012.","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0565-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-019-0565-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0565-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T00:24:29Z","timestamp":1608855869000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-019-0565-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["565"],"URL":"https:\/\/doi.org\/10.1186\/s13195-019-0565-1","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"22 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Regional Ethics Committee in Lund, Sweden, approved the study design. All patients gave their written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"OH has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun. In the past 2\u2009years, he has received consultancy\/speaker fees (paid to the institution) from Lilly, Roche, and Fujirebio.JZKC and SJB declare that they have no competing interests.JLC has provided consultation to Acadia, Accera, Actinogen, Alkahest, Allergan, Alzheon, Avanir, Axsome, BiOasis Technologies, Biogen, Diadem, EIP Pharma, Eisai, Genentech, Green Valley, Grifols, Hisun, Idorsia, Kyowa Kirin, Lilly, Lundbeck, Merck, Otsuka, Proclara, QR, Resverlogix, Roche, Samus, Samumed, Sunovion, Suven, Takeda, Teva, Toyama, and United Neuroscience pharmaceutical and assessment companies. JLC acknowledges funding from the National Institute of General Medical Sciences (Grant: P20GM109025) and support from Keep Memory Alive.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}